Setinel lymph node biopsy using superparamagnetic iron oxide and magnetic probe for oral cancer patients

Setinel lymph node biopsy using superparamagnetic iron oxide and magnetic probe for oral cancer patients - SLNB using magnetic probe for oral cancer

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000025426

Enrollment

Registered

2016-12-27

Start date

2016-12-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral cancer

Interventions

Superparamagnetic iron oxide (0.4-1.2 ml)is injected around oral cancer 1 day before surgery, and sentinel lympho node mappling is performed using MR lymphography. During surgery, sentinel lymph node

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Early stage oral cancer patients without cervical lymph node metastasis (T1-2N0). Untreated oral cancer patients.

Exclusion criteria

Exclusion criteria: Patients with allergy of iron or iodine agent, pregnacy, asthma, or renal dysfunction.

Design outcomes

Primary

Measure	Time frame
Identification and biopsy of sentinel lymph node	—

Countries

Japan

Contacts

Public ContactToshinori Iwai

Yokohama City University Hospital Department of Oral and Maxillofacial Surgery/Orthodontics

iwai104oams@yahoo.co.jp+819030021548

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026